RSPO1/Lgr5 axis activates Wnt/β-catenin signaling and promotes EMT and tumor formation in breast cancer and glioblastoma [60] whilst, by enhancing TGFβ-mediated growth inhibition and stress-induced apoptosis, it suppresses metastasis in colon cancer [24]. Here, LGR5 is linked to breast carcinoma.